Cerebral thromboembolic risk in atrial fibrillation ablation: a direct comparison of vitamin K antagonists versus non-vitamin K-dependent oral anticoagulants.
Adrian M PetzlMichael DerndorferGeorgios KolliasKgomotso MorokaJosef AichingerHelmut PürerfellnerMartin MartinekPublished in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2020)
In patients undergoing AF ablation, we identified the use of NOAC and intraprocedural cardioversion as independent risk factors for the occurrence of periprocedural cerebral embolic lesions.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- catheter ablation
- left atrial
- patients undergoing
- direct oral anticoagulants
- left atrial appendage
- subarachnoid hemorrhage
- percutaneous coronary intervention
- heart failure
- risk assessment
- cerebral ischemia
- cerebral blood flow
- radiofrequency ablation
- acute coronary syndrome
- mitral valve